Telehealth Support for Young Cancer Patients
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
Recruiting
Phase 3
Interventional Study
Cancer
Fertility Preservation
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 0 – 50
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 2,800 (estimated)
- Sponsor
- University of California, San Diego · Other
Who this trial is looking for
This trial is looking for young cancer patients who want to learn about preserving their fertility. Participants will receive support to help them engage in fertility care while they are undergoing cancer treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with cancer or have a cancer relapse
- I am receiving oncology care at a participating clinical site
- I am between 0 and 42 years old if I am female
- I am between 0 and 50 years old if I am male
- I speak English or Spanish
You may not be able to join if
- I have non-melanoma skin cancer
- I have metastatic or Stage IV non-thyroid solid tumors
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with observing and gathering information on how the intervention is implemented. The investigators hypothesize that implementation of the intervention will result in increased young cancer survivors' engagemen…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Newly diagnosed cancer or cancer relapse
* Primary language English or Spanish
* Receiving oncology care at participating clinical sites
* Ages 0 to 42 years if female
* Ages 0 to 50 years if male
Exclusion Criteria:
* Non-melanoma skin cancer, because primary treatment is e…
Contacts